跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,438 条关于
“Cereblon E3 ubiquitin ligase”
全部
1,438
临床试验
985
药物
265
机构
7
资讯
181
去年
Bavdegalutamide (ARV-110) Shows Promise as AR Degrader in Preclinical Prostate Cancer Models
28天前
Identification and Characterization of Mitochondrial E3 Ubiquitin Protein Ligase 1 (MUL1) in Disease Regulation
去年
AbbVie and Neomorph Forge $1.64 Billion Molecular Glue Degrader Partnership for Oncology and Immunology
8个月前
Ascentage Pharma Receives FDA Clearance for Novel BTK Protein Degrader APG-3288 in B-Cell Malignancies
11个月前
Frontier Medicines Unveils DCAF2 as Novel E3 Ligase for Targeted Protein Degradation in Cancer Treatment
10个月前
Kangpu's Novel Cereblon Modulator Shows 50% Response Rate in Heavily Pre-treated Multiple Myeloma Patients
上个月
The Second Act of Thalidomide: From Teratogen to the Foundation of Targeted Protein Degradation
去年
Evotec and Bristol Myers Squibb Achieve Major Milestone in Molecular Glue Degrader Collaboration, Triggering $75M Payment
3个月前
Molecular Glue Degraders of HuR Suppress BRAF-Mutant Colorectal Cancer
去年
Kangpu's Novel Molecular Glue Modulator KPG-818 Receives IND Approval in China for Multiple Myeloma Treatment
第 1 页，共 19 页
上一页
下一页
